Drug interactions in the prescription of medical patients at hospital discharge;Interacciones entre medicamentos prescritos al alta en un servicio de medicina interna

Anales de Medicina Interna

Volumn 22, Issue 2, 2005, Pages 69-75

  Lopez Vazquez P ^a   Rodríguez Moreno, Carlos ^a   Duran Parrondo C ^a   Tato Herrero, F ^a   Rodriguez Lopez I ^b   Lado Lado, F L ^b  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Drug Interactions; Drug utilization studies; Prescriptions

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CORTICOSTEROID; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; GLYCERYL TRINITRATE; INDINAVIR; ISONIAZID; METHADONE; NEUROLEPTIC AGENT; NITRATE; OMEPRAZOLE; PREDNISOLONE; PROTON PUMP INHIBITOR; RITONAVIR; SPIRONOLACTONE; SULFONYLUREA DERIVATIVE; TELMISARTAN; VALPROIC ACID;

ADULT; AGED; ALCOHOLISM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; DIGITALIS INTOXICATION; DRUG ANTAGONISM; DRUG INDICATION; DRUG MONITORING; DRUG POTENTIATION; DRUG UTILIZATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRESCRIPTION; RETROSPECTIVE STUDY; SEPSIS; SOLID TUMOR; URINARY TRACT INFECTION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PRESCRIPTIONS, DRUG;

EID: 16844377193     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. a edición. Barcelona: Masson, 2003, p. 175-6.
2. a edición. España: Addis Internacional Ltd; 2002. p. 803-38.
3. Hansten PD, Horn JR. Managing clinically important drug interactions. St Louis: Facts and Comparisons, 2003.
4. Guédon-Moreau L, Ducrocq D, Duc MF, Quieureux Y, L'Hote C, Deligne J, et al. Absolute contraindications in relation to potencial drug interactions in outpatient prescripcions: analysis of the first five million prescriptions in 1999. Eur J Clin Pharmacol 2003; 59: 689-95.
5. Recalde JM, Zunzunegui MV, Beland F. Interacciones entre medicamentos prescritos en la población mayor de 65 años. Aten Primaria 1998; 22: 434-9.
6. Calvet A, Díez M. Pérez MT. Esteras J. Interacciones farmacológicas en tratamientos crónicos: medidas correctoras para su prevención en un área básica de salud rural. Aten primaria 2001; 27: 91-6.
7. García A. García MA, Morilla J. Lobato F, Portillo J, Pérez A. Detección de interacciones medicamentosas en pacientes crónicos mediante un programa informático. Utilidad práctica en un centro de salud. Aten primaria. 1997; 19: 138-41.
8. Sáenz Calvo A, Ausejo Segura M, Cruz Martos E. González Álvaro A, Pérez Cayuela P, Rosado López A. Drug-to-drug interactions and pharmaceutical advice. Aten Primaria 1996; 17: 559-63.
9. Comet D, Casajuana J, Bordas JM, Fuentes MA, Arnaiz JA, Nunez B, et al. Drug interactions in chronic prescription. Aten Primaria. 1997; 20: 71-4.
10. Sierra P, Castillo J, Gómez M. Sorribes V, Monterde J, Castano J. Potential and real drug interactions in critical care patients. Rev Esp Anestesiol Reanim 1997; 44: 383-7.
11. Dasta JF. Drug use in a surgical intensive care unit. Drug Intell Clin Pharm 1986; 20: 752-6.
12. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38: 666-71.
13. Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med 1990; 112: 61-4.
14. Gaddis GM, Holt TR, Woods M. Drug interactions in at-risk emergency department patients. Acad Emerg Med 2002; 9: 1162-7.
15. Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation 2001; 49: 283-8.
16. Geppert U, Beindl W, Hawranek T, Hintner H. Drug interactions in clinical practice. A pilot project for quality assurance in prescribing. Hautarzt 2003; 54: 53-7.
17. Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Weite T, Boger RH. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000; 38: 504-13.
18. Egger SS, Drewe J, Schlienger RG. Potencial drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 2003; 58: 773-8.
19. Rosso C, Geniz MA, Serrani MI. Factures fisiológicos que condicionan la respuesta a los fármacos. En: SEFC (ed). Manual del residente de farmacología clínica. 1° edición, Barcelona. 2002, p. 398-9.
20. Micromedex. Drug-Reax. Greenwood Village, Colorado, Volumen 113, 2002.
21. Yen-Fu C, Avery AJ, Neil K, Johnson C, Dewey ME, Stockley IH. Assessing de occurrence and preventability of prescribing potentially hazardous/ contraindicated drug combinations in general (family) practice. Pharmacoepidemiol Drug Safety 2001; 10: S53.
22. Wrenger E, Muller R, Moesenthin M, Welte T, Frolich JC, Neumann KH. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. BMJ 2003; 327: 147-9.
23. Durán Parrondo C, Rodríguez Moreno C, Tato Herrero F, Alonso Vence N, Lado Lado FL. Oral anticoagulation. An Med Interna (Madrid) 2003; 20: 377-84.
24. Mundet X, Artaza MA, Vidal X, Arnau JM. The use of digoxin in primary care. Aten Primaria 1992; 9: 239-44.
25. Mundet X, Vidal X, Arnau JM. The characteristics of digoxin utilization in a population under emergency care for heart failure or auricular fibrillation. Med Clin 1993; 100: 94-7.
26. Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289; 871-8.
27. Fernando B, Savelyich BS, Avery AJ, Sheikh A, Bainbridge M, Horsfield P, et al. Prescribing safety features of general practice computer systems: evaluation using simulated test cases. BMJ 2004; 328; 1171-2.
28. Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther; 27: 377-82.
29. Juurlink D, Muhammad M, Kopp A, Laupacis A, Redelmeier D. Drug-drug interactions among elderly patients hospitalised for drug toxicity. JAMA 2003; 289: 1652-58
30. Sakiara L, Nagib A. Risk of drug interaction: combination of antidepressants and other drugs. Rev Saúde Pública 2003; 37: 212-5
31. Tamblyn R, Huang A, Perreault R, Jacques A, Roy D, Hanley J, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ 2003; 169: 549-56.
32. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.
33. a edición. Barcelona: Pharma Editores S.L., 2003.